Andere Sprachen Porton Pharma Solutions Ltd.

Aktien

300363

CNE100001S57

300363

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
16.81 ^CNY	-1.70%		+3.32%	-33.16%

26.04.	Porton Pharma Solutions Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
26.04.	Porton Pharma Solutions Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26.04.
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26.04.
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	09.04.
Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.	09.04.
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	03.04.
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	03.01.
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	27.10.23
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	27.10.23
Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.	15.09.23
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18.08.23
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023	28.04.23
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	21.04.23
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022	18.04.23
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders	03.04.23
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022	27.03.23
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24.03.23
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility	20.01.23
China’s Porton to set up biotech park in Slovenia’s Menges	10.01.23
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.	22.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Porton Pharma Solutions Ltd.

Aktien

300363

CNE100001S57

300363

Andere Sprachen

Filter